Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy
Conservative Local Treatment Versus Mastectomy After Induction Chemotherapy In Locally Advanced Breast Cancer: A Randomized Phase III Study
Sponsor: Central and Eastern European Oncology Group
Terminated
low accrual
Other Breast Cancer trials with similar outcome
This PHASE3 trial investigates Breast Cancer and is currently terminated or withdrawn. Central and Eastern European Oncology Group leads this study, which shows 5 recorded versions since 2001 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE3
First recorded
Oct 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Central and Eastern European Oncology Group
- European Organisation for Research and Treatment of Cancer - EORTC
- Grupo Oncologico Cooperativo Chileno de Investigation
- International Collaborative Cancer Group
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Amsterdam, Netherlands , Arnhem, Netherlands , Brussels, Belgium , Coimbra, Portugal , Gdansk, Poland , Haifa, Israel , Leiden, Netherlands , Leuven, Belgium , London, United Kingdom , Poznan, Poland and 3 more locations